(Press-News.org) September 8, 2014 – Hamilton, ON – A team of researchers at McMaster University and St. Joseph's Healthcare Hamilton have successfully evaluated a new, antibody-based drug for certain patients with severe asthma. The drug – named mepolizumab – can replace traditional, steroid-based treatments for a specific subset of patients, resulting in improved outcomes and reduced side effects.
The study and manuscript, published in the New England Journal of Medicine was led in Canada by Dr. Parameswaran Nair, staff respirologist, Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton and professor of respirology at the Michael G. DeGroote School of Medicine at McMaster University. Dr. Nair and his colleagues recruited the largest number of participants for this global study.
"This new drug is the only therapy that has been proven to be effective in well-established clinical trials to help reduce doses of steroid-based treatments such as prednisone for those with severe asthma," said Dr. Nair, adding that the paper reconfirms the team's observation published in the New England Journal of Medicine in 2009.
Patients with severe asthma often require high doses of steroid-based treatments that can significantly impair their quality of life. These high doses can cause debilitating side effects including mood swings, diabetes, bone loss, skin bruising, cataracts and hypertension.
Previous research at the Hamilton institutions has identified specific types of patient with severe asthma have an overabundance of a particular type of white blood cell (eosinophils) present in their sputum. These patients often suffer from the most severe asthma symptoms and can only be treated through steroid-based medications such as prednisone.
"This is an exciting example of personalized medicine for asthma," said Nair. "This discovery now tells us by using a simple blood or sputum eosinophil count, we can identify which asthma patients can benefit from this new treatment.
INFORMATION:
Researchers improve severe asthma care through new, antibody-based treatment
2014-09-09
ELSE PRESS RELEASES FROM THIS DATE:
Patients with advanced dementia continue receiving medications of questionable benefit
2014-09-08
Bottom Line: More than half of nursing home residents with advanced dementia (a terminal illness marked by severe cognitive impairment and functional dependence) continue to receive medications of questionable benefit (including medications to treat dementia and lower cholesterol) at substantial financial cost.
Author: Jennifer Tjia, M.D., M.S.C.E., of the University of Massachusetts Medical School, Worcester, and colleagues.
Background: The Institute of Medicine recommends clinicians minimize interventions in patients with life-limiting disease and instead focus ...
Access to care among young adults increases after health insurance expansion
2014-09-08
Bottom Line: Health insurance coverage increased, as expected, among 19- to 25-year-olds after the Patient Protection and Affordable Care Act (PPACA) allowed them to remain on their parents' insurance longer but there were no significant changes in perceived health status or the affordability of health care.
Author: Meera Kotagal, M.D., M.P.H., of the University of Washington, Seattle, and colleagues.
Background: Nearly 1 in 3 young adults ages 19 to 25 years lacked health insurance in 2009. An early provision of the PPACA implemented in 2010 mandated that insurance ...
Study examines immunosuppressant effect on central nervous system disorder
2014-09-08
Bottom Line: In patients with neuromyelitis optica spectrum disorder (NMOSD, an autoimmune inflammatory disease of the central nervous system similar to multiple sclerosis but even more debilitating), the immunosuppressant medication mycophenolate mofetil (MMF) appears to reduce the frequency of relapse, stabilize or improve disabilities and be well tolerated by patients.
Author: So-Young Huh, M.D., of the University College of Medicine, Busan, Korea, and colleagues.
Background: Disabilities from NMOSD arise due to acute attacks and just one or two attacks can lead ...
JAMA Internal Medicine commentary: 'Improving Prescribing for Patients Late in Life'
2014-09-08
INDIANAPOLIS -- Older adults are typically prescribed a large number of medications, often including drugs that should not be taken by individuals late in life. In a commentary published online by JAMA Internal Medicine on September 8, Regenstrief Institute investigator Greg Sachs, M.D., calls for physicians to carefully review older patients' medication lists.
According to Dr. Sachs, current prescribing guidelines fail to adequately address instances in which specific drugs are not beneficial or may even be harmful to older adults. Current guidelines also fail to identify ...
Sodium's influence on blood pressure statistically insignificant
2014-09-08
A new study published in American Journal of Hypertension finds evidence that increased Body Mass Index, age, and non-sodium dietary factors are much more closely related to increases in systolic blood pressure than sodium intake.
The study, "Relationship between nutrition and blood pressure: A cross-sectional analysis from the NutriNet-Santé study, a French web-based cohort study," measured the effects of sodium intake, Body Mass Index, physical activity, alcohol consumption, and non-sodium dietary factors on the blood pressure of 8,670 French adults and concluded ...
Agricultural revolution in Africa could increase global carbon emissions
2014-09-08
WEST LAFAYETTE, Ind. - Productivity-boosting agricultural innovations in Africa could lead to an increase in global deforestation rates and carbon emissions, a Purdue University study finds.
Historically, improvements in agricultural technology have conserved land and decreased carbon emissions at the global level: Gaining better yields in one area lessens the need to clear other areas for crops, sidestepping a land conversion process that can significantly raise the amount of carbon dioxide released into the atmosphere.
Agricultural advances in Africa, however, could ...
Watchful waiting isn't right for everyone
2014-09-08
(PHILADELPHIA) – There is an active controversy among oncologists about when to treat prostate cancer patients, with some suggesting that the word "cancer" be removed from the description of low grade disease, in order to prevent overtreatment. However a new study shows that these guidelines may not be appropriate for everyone, especially African American men.
"We know that African American men have more aggressive prostate cancer than Caucasian men," says Kosj Yamoah M.D., Ph.D., Chief Resident, Department of Radiation Oncology at Thomas Jefferson University. "Our study ...
Study traces ecological collapse over 6,000 years of Egyptian history
2014-09-08
Depictions of animals in ancient Egyptian artifacts have helped scientists assemble a detailed record of the large mammals that lived in the Nile Valley over the past 6,000 years. A new analysis of this record shows that species extinctions, probably caused by a drying climate and growing human population in the region, have made the ecosystem progressively less stable.
The study, published September 8 in Proceedings of the National Academy of Sciences (PNAS), found that local extinctions of mammal species led to a steady decline in the stability of the animal communities ...
Broken signals lead to neurodegeneration
2014-09-08
Researchers from the RIKEN Brain Science Institute in Japan, in collaboration with Juntendo University and the Japan Science and Technology Agency, have discovered that a cell receptor widely involved in intracellular calcium signaling--the IP3R receptor--can be locked into a closed state by enzyme action, and that this locking may potentially play a role in the reduction of neuron signaling seen in neurodegenerative diseases such as Huntington's and Alzheimer's disease.
In the research published today in the Proceedings of the National Academy of Sciences, the scientists ...
In directing stem cells, study shows context matters
2014-09-08
MADISON, Wis. — Figuring out how blank slate stem cells decide which kind of cell they want to be when they grow up — a muscle cell, a bone cell, a neuron — has been no small task for science.
Human pluripotent stem cells, the undifferentiated cells that have the potential to become any of the 220 types of cells in the body, are influenced in the lab dish by the cocktail of chemical factors and proteins upon which they are grown and nurtured. Depending on the combination of factors used in a culture, the cells can be coaxed to become specific types of cells.
Now, in ...